The cytoskeleton is an essential element of a eukaryotic cell which informs both form and function and ultimately has physiological consequences for the organism. Equally as important as the major cytoskeletal networks are crosslinkers which coordinate and regulate their activities. One such category of crosslinker is the spectraplakins, a family of giant, evolutionarily conserved crosslinking proteins with the rare ability to interact with each of the three major cytoskeletal networks. In particular, a mammalian spectraplakin isotype called MACF1 (microtubule actin crosslinking factor 1), also known as ACF7 (actin crosslinking factor 7), has been of particular interest in the years since its discovery; MACF1 has come under such scrutiny due to the mounting list of biological phenomena in which it has been implicated. This review is an overview of the current knowledge on the structure and function of the known spectraplakin isotypes with an emphasis on MACF1, recent studies on MACF1, and finally, an analysis of the potential of MACF1 to advance medicine.
Impact statement
Spectraplakins are a highly conserved group of proteins which have the rare ability to bind to each of the three major cytoskeletal networks. The mammalian spectraplakin MACF1/ACF7 has proven to be instrumental in many cellular processes (e.g. signaling and cell migration) since its identification and, as such, has been the focus of various research studies. This review is a synthesis of scientific reports on the structure, confirmed functions, and implicated roles of MACF1/ACF7 as of 2019. Based on what has been revealed thus far in terms of MACF1/ACF7’s role in complex pathologies such as metastatic cancers and inflammatory bowel disease, it appears that MACF1/ACF7 and the continued study thereof hold great potential to both enhance the design of future therapies for various diseases and vastly expand scientific understanding of organismal physiology as a whole.
EricksonHP.The discovery of the prokaryotic cytoskeleton: 25th anniversary. Mol Biol Cell2017;
28:357–8
4.
VatsPRothfieldL.Duplication and segregation of the actin (MreB) cytoskeleton during the prokaryotic cell cycle. Proc Natl Acad Sci U S A2007;
104:17795–800
5.
OjimaIKumarKAwashthiDVinebergJG.Drug discovery targeting cell division proteins, microtubules and FtsZ. Bioorg Med Chem2014;
22:5060–77
6.
AlhusseinGShantiAFarhatIATimrazSBAlwahabNSPearsonYEMartinMNChristoforouNTeoJC.A spatiotemporal characterization method for the dynamic cytoskeleton. Cytoskeleton2016;
73:221–32
7.
YangWGuoXTheinSXuFSugiiSBaasPWRaddaGKHanW.Regulation of adipogenesis by cytoskeleton remodelling is facilitated by acetyltransferase MEC-17-dependent acetylation of α-tubulin. Biochem J2017;
449:605–12
8.
Mangas-SanjuanVOláhJGonzalez-AlvarezILehotzkyATökésiNBermejoMOvádiJ.Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors. Br J Pharmacol2015;
172:829–40
9.
BasuSLamprechtR.The role of actin cytoskeleton in dendritic spines in the maintenance of long-term memory. Front Mol Neurosci2018;
11:143
10.
HeMZhangZ-HGuanC-BXiaDYuanX-B.Leading tip drives soma translocation via forward f-actin flow during neuronal migration. J Neurosci2010;
30:10885–98
11.
SuozziKCWuXFuchsE.Spectraplakins: master orchestrators of cytoskeletal dynamics. J Cell Biol2012;
197:465–75
MachnickaBCzogallaAHryniewicz-JankowskaABoguslawskaDMGrochowalskaRHegerESikorskiAF.Spectrins: a structural platform for stabilization and activation of membrane channels, receptors and transporters. Biochim Biophys Acta2014;
1838:620–34
14.
HuLHuangZWuZAliAQianA.Mammalian plakins, giant cytolinkers: versatile biological functions and roles in cancer. Int J Mol Sci2018;
19:E974
15.
QianAHuL.Spectraplakins, versatile roles in physiology and pathology. Semin Cell Dev Biol2017;
69:1–2
16.
LiemR.Cytoskeletal integrators: the spectrin superfamily. Cold Spring Harb Perspect Biol2016;
8:a018259
17.
VoelzmannALiewYTQuY.Drosophila Short stop as a paradigm for the role and regulation of spectraplakins. Semin Cell Dev Biol2017;
69:40–57
18.
FuRJiangXHuangZZhangH.The spectraplakins of Caenorhabditis elegans: Cytoskeletal crosslinkers and beyond. Semin Cell Dev Biol2017;
69:58–68
19.
Sanchez-SorianoNTravisMDajas-BailadorFGonçalves-PimentelCWhitmarshAJProkopA.Mouse ACF7 and Drosophila short stop modulate filopodia formation and microtubule organisation during neuronal growth. J Cell Sci2009;
122:2534–42
20.
MoffatJJKaMJungEMSmithALKimWY.The role of MACF1 in nervous system development and maintenance. Semin Cell Dev Biol2017;
69:9–17
21.
AntonellisPJPollockLMChouSWHassanAGengRChenXFuchsEAlagramamKNAuerMMcDermottBMJr.ACF7 is a hair-bundle antecedent, positioned to integrate cuticular plate actin and somatic tubulin. J Neurosci2014;
34:305–12
22.
Escobar-AguirreMElkoubyYMMullinMC.Localization in oogenisis of maternal regulators of embryonic development. Adv Exp Med Biol2017;
953:173–207
23.
HuLSuPLiRYinCZhangYShangPYangTQianA.Isoforms, structures, and functions of versatile spectraplakin MACF1. BMB Rep2016;
49:37–44
24.
ZhangJYueJWuX.Spectraplakin family proteins – cytoskeletal crosslinkers with versatile roles. J Cell Sci2017;
130:2447–57
25.
BouameurJEFavreBBorradoriL.Plakins, a versatile family of cytolinkers: roles in skin integrity and in human diseases. J Invest Dermatol2014;
134:885–94
26.
RöperKGregorySLBrownNH.The 'spectraplakins': cytoskeletal giants with characteristics of both spectrin and plakin families. J Cell Sci2002;
115:4215–25
27.
LaneTRFuchsESlepKC.Structure of the ACF7 EF-hand-GAR module and delineation of microtubule binding determinants. Structure2017;
25:1130–8.e6
28.
AntolikCCatinoDHO’Neill ResneckWGUrsittiJABlotchRJ.The actin binding domain of acf7 binds directly to the tetratricopeptide repeat domains of rapsyn. Neuroscience2008;
145:56–65
29.
DadayCKolšekK.Gräter The mechano-sensing role of the unique SH3 insertion in plakin domains revealed by Molecular Dynamics simulations. Sci Rep2017;
7: 11669
30.
BagurRHanjnóczkyG.Intracellular Ca2+ sensing: its role in calcium homeostasis and signaling. Mol Cell2017;
66:780–8
31.
KangHWeissTMBangIWeisWIChoiHJ.Structure of the intermediate filament-binding region of desmoplakin. PLoS One2016;
11:e0147641
32.
FoglCMohammedFAl-JassarCJeevesMKnowlesTJRodriguez-ZamoraPWhiteSAOdintsovaEOverduinM.Mechanism of intermediate filament recognition by plakin repeat domains revealed by envoplakin targeting of vimentin. Nat Commun2016;
7:10827
33.
GongTWLBesirliCGLomaxMI.MACF1 gene structure: a hybrid of plectin and dystrophin. Mamm Genome2001;
12:852–61
34.
MiaoZAliAHuL.Microtubule actin cross-linking factor 1, a novel potential target in cancer. Cancer Sci2017;
108:1953–8
35.
ZhaoWQianHZhangRGaoXGouX.MicroRNA targeting microtubule cross-linked protein (MACF1) would suppress the invasion and metastasis of malignant tumor. Med Hypotheses2017;
104:25–9
36.
ShiCLiHQuX.High fat diet exacerbates intestinal barrier dysfunction and changes gut microbiota in intestinal-specific ACF7 knockout mice.Biomed Pharmacother2018;
110:537–45
37.
MaYYueJZhangYShiCOdenwaldMLiangWGWeiQGoelAGouXZhangJChenSYTangWJTurnerJRYangFLiangHQinHWuX.ACF7 regulates inflammatory colitis and intestinal wound response by orchestrating tight junction dynamics. Nat Commun2017;
8:15375
38.
DuhamelSGoyetteMAThibaultMPFilionDGabouryLCôtéJF.The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP ACF7 for degradation. Cell Rep2018;
22:1016–30
39.
AfghaniNMehtaTWangJTangNSkalliOQuickQA.Microtubule actin cross-linking factor 1, a novel target in glioblastoma. Int J Oncol2017;
50:310–6
40.
QuickQA.Microtubule-actin crosslinking factor 1 and plakins as therapeutic drug targets. Int J Mol Sci2018;
19:368
41.
BarataPSoodAKHongDS.RNA-targeted therapeutics in cancer clinical trials: Current status and future directions. Cancer Treat Rev2016;
50:35–47
42.
HuLXiaoYXiongZ.MACF1, versatility in tissue-specific function and in human disease. Semin Cell Dev Biol2017;
69:3–8
43.
AtreyaRNeurathM.Current and future targets for mucosal healing in inflammatory bowel disease. Visc Med2017;
33:82–8
44.
DulaiPSSandbornWJGuptaS.Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology, and management. Cancer Prev Res2016;
9:887–94
45.
RapozoDCMBernadazziCPerereira da SouzaHS.Diet and microbiota in inflammatory bowel disease: The gut in disharmony. World J Gastroenterol2017;
23:2124–40
46.
WangQLiMYangZHuXWuHMNiPRenHDengWLiMMaXGuoWZhaoLWangYXiangBLeiWShamPCLiT.Increased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal development. Sci Rep2015;
5:18209
47.
DobynsWBAldingerKAIshakGEMirzaaGMTimmsAEGroutMEDremmenMHGSchotRVandervoreLvan SlegtenhorstMAWilkeMKasteleijnELeeASBarryBJChaoKRSzczałubaKKoboriJHanson-KahnABernsteinJACarrLD'ArcoFMiyanaKOkazakiTSaitoYSasakiMDasSWheelerMMBamshadMJNickersonDA, University Of Washington Center For Mendelian Genomics Center For Mendelian Genomics At The Broad Institute Of MIT, Harvard EngleECVerheijenFWDohertyDManciniG.MACF1 mutations encoding highly conserved zinc-binding residues of the GAR domain cause defects in neuronal migration and axon guidance. Am J Hum Genet2018;
103:1009–21
